GlassScriptPhysician profile
Brian S Shafa
NPI 1811258726
$2,615.22
in general payments reported to CMS, 2019-2025
17 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.66 · 2020: $42.78 · 2021: $387 · 2022: $352 · 2023: $699 · 2024: $897 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,118.93 | 2023-2025 | |
| Allergan, INC. | $393.33 | 2019-2021 | |
| Novo Nordisk INC | $266.04 | 2022-2024 | Wegovy, Saxenda |
| Merz North America, INC. | $238.10 | 2020-2024 | |
| Integra Lifesciences Corporation | $118.86 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Vertex Pharmaceuticals Incorporated | $69.72 | 2025 | |
| Bioventus LLC | $69.50 | 2022-2023 | |
| Revance Therapeutics, INC. | $66.32 | 2024 | Daxi |
| Lilly USA, LLC | $55.83 | 2023-2024 | Zepbound |
| Smith+Nephew, INC. | $35.38 | 2021-2023 | Grafix |
| Mentor Worldwide LLC | $34.19 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $30.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Lifenet Health | $30.85 | 2023 | |
| Tela Bio, INC. | $24.30 | 2024 | Ovitex 2s |
| Nestle Healthcare Nutrition INC. | $23.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $21.14 | 2023 | |
| Phadia US INC. | $18.12 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.